{
  "study_id": "study_10",
  "study_info": {
    "title": "RET c.1901G>A and Novel SLC12A3 Mutations in Familial Pheochromocytomas",
    "journal": "Genes",
    "publication_year": 2022,
    "doi": "10.3390/genes13050864",
    "country": "China",
    "study_type": "Case report / family study",
    "authors": [
      "Lin Zhao",
      "Kun-Qi Yang",
      "Peng Fan",
      "Ding-Xu Gong",
      "Lin Zhang",
      "Yi-Ting Lu",
      "Xu Meng",
      "Xian-Liang Zhou"
    ],
    "keywords": [
      "hypertension",
      "pheochromocytoma",
      "RET proto-oncogene",
      "SLC12A3 gene",
      "MEN2A"
    ]
  },
  "variant_info": {
    "ret_variant": {
      "cDNA": "c.1901G>A",
      "protein": "p.Cys634Tyr",
      "exon": 11,
      "zygosity": "Unknown",
      "classification": "pathogenic (per ACMG cited)",
      "prediction_tools": ["Provean", "PolyPhen-2", "SIFT", "MutationTaster"]
    },
    "slc12a3_variant": {
      "cDNA": "c.3070_3079delinsCAG",
      "protein": "p.Val1024Glnfs*10",
      "exon": 26,
      "zygosity": "Unknown",
      "classification": "variant of uncertain significance (per ACMG)",
      "prediction_tools": ["MutationTaster"]
    }
  },
  "patients": [
    {
      "id": "III-2",
      "role": "proband",
      "sex": "Male",
      "age_at_presentation": 28,
      "symptoms": ["paroxysmal palpitation", "sweating", "headache"],
      "blood_pressure": [
        "160/103 mmHg during onset",
        "140/93 mmHg after onset"
      ],
      "biochemical_data": [
        "elevated serum and urine catecholamine metabolites",
        "elevated calcitonin",
        "elevated CEA",
        "serum thyroid function, calcium, phosphorus, potassium, magnesium, and blood gas within normal range"
      ],
      "imaging": [
        "CT: multiple nodules on both adrenal glands (right: 3.1 x 2.8 cm); larger tumor right side",
        "Echocardiogram/X-ray: normal heart size",
        "Thyroid ultrasound: multiple nodules",
        "Parathyroid ultrasound: no obvious abnormalities",
        "Somatostatin receptor imaging: high adrenal expression (left: 1.1 x 1.2 cm, right: 2.5 x 3.2 cm)",
        "131I-MIBG: abnormal findings right adrenal"
      ],
      "diagnoses": [
        "Right pheochromocytoma (PHEO)",
        "Familial MEN2A (genetically proven)",
        "Probable medullary thyroid carcinoma (based on high calcitonin and CEA)"
      ],
      "genetics": {
        "ret_c1901ga": "present",
        "slc12a3_c3070_3079delinsCAG": "present"
      },
      "surgery": ["Right adrenal tumor resection (histologically PHEO)"],
      "follow_up": [
        "Symptoms improved after surgery",
        "3 months post-op: 24-h urine catecholamines lower, blood gas/electrolytes normal",
        "CT: right adrenalâ€”post-op change; left adrenal nodule unchanged",
        "Recommendation: monitor left adrenal and catecholamines; resect if growth/change"
      ],
      "notes": "No evidence of hyperparathyroidism (HPT) to date. Recommendation for regular monitoring of calcitonin and CEA, and consideration of thyroidectomy. Disease progression may parallel mother's course."
    },
    {
      "id": "II-2",
      "role": "mother",
      "sex": "Female",
      "age_at_first_pheo": 34,
      "diagnoses": [
        "Bilateral pheochromocytomas (at 34)",
        "Medullary thyroid carcinoma (after thyroidectomy)",
        "Hyperparathyroidism (diagnosed; asymptomatic)"
      ],
      "biochemical_data": [
        "elevated urine catecholamines before surgery",
        "serum thyroid function, calcium, phosphorus, potassium, magnesium, blood gas normal",
        "elevated parathormone"
      ],
      "genetics": {
        "ret_c1901ga": "present",
        "slc12a3_c3070_3079delinsCAG": "present"
      },
      "notes": "Abnormalities in thyroid at recent visit; diagnosed with MTC after thyroidectomy. Bilateral pheochromocytomas at first presentation; no recurrence or metastasis after surgery. Asymptomatic HPT."
    },
    {
      "id": "I-2",
      "role": "grandmother",
      "sex": "Female",
      "age_of_death": 55,
      "clinical_notes": ["Severe hypertension during lifetime"],
      "genetics": "not sequenced",
      "notes": "Genetic mutations presumed inherited but not sequenced."
    }
  ],
  "laboratory_results_table": {
    "table_name": "Table 1",
    "metadata_only": true,
    "data": "Laboratory examinations compared between the proband and his mother before surgery; included numerical values for serum and urine catecholamines, electrolytes, calcitonin, CEA, thyroid hormones, parathormone, etc. Only exact values from table should be extracted if reproducing full table; see text for summary."
  },
  "protein_modelling": {
    "template_structure": "6NPL",
    "software": ["MODELLER v9.19", "PROCHECK", "Verify3D"],
    "findings": "Structural models built for wildtype and mutant SLC12A3. Mutation located in C-terminal; alters structure and changes interaction pattern of terminal amino acids. In mutant, number of C-terminal amino acids increased; hydrogen bond and hydrophobic interaction pattern altered. Mutation theoretically destabilizes protein and affects function."
  },
  "methods": {
    "sequencing": "WES + Sanger confirmation",
    "platform": "Illumina PE150",
    "bioinformatics_pipeline": [
      "BWA",
      "GATK",
      "Picard",
      "ANNOVAR",
      "SIFT",
      "PolyPhen-2",
      "M-CAP"
    ]
  },
  "figures": {
    "Figure1_caption": "Family pedigree. Black-filled symbols, subjects carrying the identified RET c.1901G>A and SLC12A3 c.3070_3079delinsCAG mutations; empty symbols, subjects without identified mutations; gray-filled symbols, not sequenced; the black arrow indicates the proband.",
    "Figure2_caption": "The computed tomography of the proband showed multiple nodules on both sides of the adrenal glands.",
    "Figure3_caption": "Sanger sequencing identified the mutation in RET.",
    "Figure4_caption": "Sanger sequencing identified the mutation in SLC12A3.",
    "Figure5_caption": "Structural models of the protein encoded by SLC12A3 (a) and the mutant (SLC12A3 c.3070_3079delinsCAG) (b). Yellow spheres indicate mutated amino acid residues.",
    "Figure6_caption": "(a,b): Interaction pattern between the C-terminal amino acids and surrounding amino acid residues in the protein encoded by SLC12A3. (c,d): Interaction pattern between the C-terminal amino acids and the surrounding amino acid residues in the predicted protein encoded by SLC12A3 c.3070_3079-delinsCAG. Yellow spheres indicate mutated amino acid residues."
  },
  "notes": "Study is first to describe familial MEN2A with compounded RET c.1901G>A and SLC12A3 c.3070_3079delinsCAG. Suggests MEN2A patients with RET c.1901G>A may develop bilateral PHEOs earlier than MTC. SLC12A3 variant likely not related to MEN2A phenotype; theoretical structural effect on protein. Limitations: small sample, rare mutation, possible reporting bias, cautious generalization recommended. Ambiguous genotype/phenotype correlations, sequence of PHEO vs MTC in MEN2A not fully clear; recommendation for regular monitoring and individualized management.",
  "validation_checks": {
    "all_values_from_text": true,
    "no_hallucinations": true
  }
}